Latest Articles

This article explores the importance of testing for liver-related autoantibodies to differentiate between three autoimmune liver diseases.

Current automated insulin delivery systems for Type 1 diabetics struggle to regulate blood glucose effectively during exercise, but integrating data from wearable fitness sensors and AI could change that, a recent study suggests.

Biopharmaceuticals require careful analysis during research, development and manufacturing. In this article, we highlight some of the analytical techniques employed in biopharmaceutical analysis, and how the field is evolving to meet new challenges.

Digitalization underpins the biopharma industry’s endeavors to keep up with innovation and get life-changing therapeutics into the hands of patients as quickly as possible. This article explores how a digital backbone can help to realize the full potential of data and generate meaningful insights.

Geoff Dance highlights how automation can help us explore the unknown in the cell-cultured meat industry.

Biomarkers can potentially aid patient management across the stages of their disease course. This article will review advances in computationally-driven biomarker discovery, including from metabolomics datasets, for complex, multifactorial diseases.

Scientists have devised an environmentally friendly method that turns vegetable waste into health and personal care products, giving vegetable waste a new lease of life in a sustainable and cost effective manner.

Ketamine is increasingly used as an antidepressant. A new clinical trial suggests the drug's effects may be may be placebo-based. In this article, we explore what that means for the drug's rollout for ketamine and psychedelic research.

Researchers explored the impact of double HER2 mutations and identified a specific combination of existing cancer drugs able to target breast cancer cells that were previously resistant to treatment.

There has been excitement surrounding single-molecule sequencing and its possible application in single-cell proteomics. We speak with Dr. Ryan Kelly to understand how its capabilities currently compare to mass spectrometry.